Investors

For more than a decade, biomedicine centers are concern with the developing of in vitro dosimeter systems, which is based on TLD (Thermoluminescent dosimeters), SD (semiconductor diodes), OSL (optically stimulated luminescence), PSD (plastic scintillation detectors), and RPLGD (radiophotoluminescent glass dosimeters) technologies. However, most of these systems have technological drawbacks and are only partially used in real life situations. This product does not possess such drawbacks.

We have received the consultations for the commercialization of prototypes from MITA, UAB “Deloitte Lietuva”, and ANTEJA ECG (while participating in the project “Technology and Science for the Innovative Business” No. VP2-1.4-ŪM-05-V-01-001).